Stories

Illinois has raised its tobacco tax from 36% to 45% as part of the 2026 budget, which now also applies to nicotine pouches like Zyn. The change, effective July 1, is expected to generate about $53 million in new revenue. Zyn pouches, popular among young people for their discreet use and flavored options, are now taxed similarly to cigarettes, though they remain cheaper—a tin starts at $5.60 before tax and about $9.92 after. By contrast, heavy taxation makes cigarettes in Chicago cost up to $20 per pack, the highest in the U.S.

The Gibraltar Government is considering legislation to ban tobacco sales to residents born after January 1, 2009. Feedback from industry and retailers highlighted economic concerns. The Minister acknowledges the addictive nature of nicotine but clarifies smoking remains legal. The goal is to prevent youth smoking and create a smoke-free environment. If approved, the law would take effect in 2027. Penalties for violating the law could be up to £10,000 for individuals and up to £20,000 for businesses. The legislation also targets single-use vapes, tobacco product imitations, and vending machine sales.

Seizures of illegal vapes are surging in the UK due to the disposable ban, driving more activity to the black market. Sussex confiscated 21,200 illicit vape products in 2024 compared to zero four years earlier. In Surrey, seizures rose from 500 to 14,140 last year. While councils see it as progress, critics say more funding is needed for Trading Standards to combat dangerous products. Industry advocates argue crackdowns on rogue traders are essential. Despite efforts, the ban on disposable vapes is backfiring, with illegal sales persisting across the UK. The rise in unlawful vapes poses health risks and undermines the vaping industry's credibility.

India's vape ban has lasted six years, despite over 1 million smoking-related deaths yearly. Doctors from AIIMS advocate for a reevaluation, suggesting e-cigarettes aid cessation. They challenge the ban despite AIIMS' support. With high tobacco use, advocates call for harm reduction policies like those in the UK. The ban failed, leading to a booming illicit market. Public health experts urge a review for a safer approach. Doctors witness smoking's harm daily, supporting a reevaluation for better public health. Researchers emphasize the need for evidence-based policies to combat smoking's devastating impact.

Cigarette smoking is the leading preventable cause of death and disease, linked to cardiovascular disease, chronic lung disease, and cancer. Novel nicotine products such as e-cigarettes and nicotine pouches can lower exposure to harmful chemicals and reduce smoking-related risks, supporting national “SmokeFree” strategies. However, their effectiveness depends on accessibility. While some advocate for prescription-only models, such restrictions may limit access for smokers and lead to unintended consequences, including black markets, crime, and health risks from unregulated products.

In India, hundreds of millions of tobacco users are kept in the dark about safer nicotine products, while the government bans popular alternatives like vaping and stays silent on even basic NRTs. Shot on location at GFN 2025 in Warsaw, Poland, Jagannath Sarangapani exposes how prohibition and the absence of relative risk messaging have shaped the country’s tobacco control strategy.

This text, based on a presentation at a conference, highlights flaws in nicotine/tobacco research, discusses harm reduction, and critiques common research flaws. It emphasizes the divisive nature of tobacco harm reduction (THR) research, industry involvement, and bias in interpreting data. Common flaws include disregarding harm continuum, misinterpreting causation, and making inappropriate policy recommendations. The author proposes that confirmation bias and peer reviewer alignment contribute to the field's polarization and declining research integrity. The complexity of nicotine/tobacco research, industry influence, and the need for critical evaluation of scientific studies are discussed.

Researchers tested the iSENZIA™ heated herbal system as a potential safer alternative for smokers, delivering nicotine with fewer harmful chemicals than cigarettes. The study found that the system produced aerosols with significantly lower levels of harmful compounds compared to cigarette smoke, supporting reduced exposure and potential harm reduction. Clinical findings showed lower nicotine delivery and satisfaction compared to cigarettes, suggesting lower abuse liability. However, long-term health impact and switching effectiveness require further study. Study limitations include a small sample size and lack of long-term outcomes.

FDA Commissioner Makary emphasized stakeholder consensus and evidence-based decisions on policy issues in a podcast, raising concerns about a "child vaping epidemic" but overlooking adult smokers' needs. Makary should prioritize alternatives for adult smokers, as evidence supports e-cigarettes as a less harmful option than combustible cigarettes. Emphasizing public education to correct misconceptions and authorizing a broader range of appealing alternatives could lead to better health outcomes. Restrictive measures, such as flavor bans, risk driving consumers to the unregulated market and increasing tobacco sales. To improve public health, FDA policies should align with evidence-based approaches and address adult smokers' needs to reduce illicit products and promote safer choices.

The ban on disposable vapes failed as manufacturers replaced them with reusable replicas, still leading to disposal. Despite the ban due to underage vaping, 5.3 million copycat vapes were sold in the first month, but only 1.4 million refills. A survey revealed users buy new devices every 16 days. Environmental concerns were raised, with many discarding vapes instead of refilling. Scott Butler warned of a potential environmental crisis. Tory MP Jack Rankin criticized the ban, suggesting it hindered adult smoking cessation efforts.